SOURCE: U.S. Sustainable Energy Corp

April 18, 2006 14:14 ET

U.S. Sustainable Energy Corporation and Nanobac Pharmaceuticals, Inc. Investigate Nanobacteria Link to Energy Production

TAMPA, FL -- (MARKET WIRE) -- April 18, 2006 -- U.S. Sustainable Energy Corporation ("U.S. Sustainable" or "the Company") announced today that it is investigating and conducting joint research with Nanobac Pharmaceuticals, Inc. ("Nanobac") (OTC BB: NNBP) on a possible connection between nanobacteria, or calcifying nano-particles, and its proprietary process for the production of biofuels from various biomass feedstocks using the Company's technologies.

The Company's technologies will include the rights to the certain patents and intellectual property rights currently contained in EarthFirst Technologies, Inc. (OTC BB: EFTI). Under EarthFirst's previously announced planned merger with Cast-Crete Corporation, EarthFirst/Cast-Crete will become the co-proponent of the Plan of Reorganization of CyberCare, Inc. ("CyberCare") (OTC: CYBR). After the merger with Cast-Crete and CyberCare's emergence from reorganization, EarthFirst/Cast-Crete intend to combine the existing energy technologies with CyberCare's technology assets. The surviving entity will be known as U.S. Sustainable Energy Corporation.

Nanobac has previously announced published research that demonstrated the role nanobacteria play in the production of electricity. A fuel cell was used to enrich a microbial consortium generating electricity. Nanobacteria-like particles were present on the biofilm surface.

John Stanton, Chairman of both Nanobac and U.S. Sustainable, stated that Nanobac's continuing research with the National Aeronantics and Space Administration ("NASA") suggests potential energy, as well as healthcare, implications of nanobacteria. Our goal is to discover, or invent, and then commercialize technologies that enhance our way of life through sustainable energy development that "does no harm" to our health, or environment.

It has been substantiated that calcific diseases propagate in microgravity because nanobacteria growth in that environment is accelerated. We are specifically investigating whether or not the vacuum created in the biofuel production process might accelerate nanobacteria growth, thus enhancing biofuel productivity.

Investors are cautioned that certain statements contained in this document as well as some statements in periodic press release and some oral statement of Nanobac Pharmaceuticals, Inc. officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-Looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future Nanobac actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-Looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and Nanobac has no specific intention to update these statements.

Contact Information

    John Stanton